ArticleFrontiers in medicine2026
Association between platelet-to-neutrophil ratio and asthma-COPD overlap: a cross-sectional study in China.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The platelet-to-neutrophil ratio (PNR) has emerged as a valuable biomarker that reflects both systemic inflammatory activity and overall nutritional status. Asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) is a clinical syndrome characterized by persistent airway inflammation and recurrent episodes of respiratory deterioration. Although inflammation represents a common underlying pathological mechanism, the relationship between PNR and the incidence or severity of ACO has not yet been fully clarified. Elucidating this association is therefore of considerable clinical and scientific importance. Methods: This cross-sectional retrospective study used multivariable logistic regression analyses to examine the association between PNR and ACO, after adjusting for key covariates, including age, sex, body mass index (BMI), hemoglobin, white blood cell count, eosinophil count, creatinine, alanine aminotransferase, aspartate aminotransferase, albumin levels, smoking history, and alcohol consumption. Restricted cubic spline (RCS) models assessed linear and non-linear relationships, while Spearman's correlation analysis evaluated the strength and direction of associations. In addition, subgroup analyses were performed to investigate potential differences across specific population groups. Results: A total of 1,025 participants were included in the analysis, with a median age of 61 years; 72.78% of the cohort were male. The study population comprised 685 healthy controls (HCs), 348 individuals with asthma, 372 with chronic obstructive pulmonary disease (COPD), and 340 with asthma-COPD overlap (ACO). Patients with ACO exhibited significantly lower PNR values than HCs ( Conclusion: This study demonstrates a significant inverse association between PNR and ACO, particularly when PNR values fall below the identified threshold of 61.17. These findings suggest that PNR may serve as a potentially valuable biomarker for assessing ACO risk. Further prospective and validation studies are warranted to confirm its diagnostic performance and clinical applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.